IASO BIO
PrivateLast Round
Series C
Extension
Sep 1, 2025
Total Funding Raised
$303.4M
Company Overview
IASO Bio is a biotechnology company that develops innovative cellular drugs for cancer biotherapeutics, focusing on cell-therapy products that target hematological tumors, solid tumors, and virus-associated tumors to enhance treatment efficacy for healthcare providers and their patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IASO BIO Comps
Public and private peers based on sector, stage, and business model.
IASO BIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Sep 1, 2025 | ||||
| Strategic | Jul 5, 2024 | ||||
| Series C Extension | Jan 18, 2023 | ||||
| Series C | Sep 16, 2021 | ||||
| Series B | Mar 24, 2020 | ||||
Series A | Oct 1, 2019 |
IASO BIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hongcheng Capital | Series C Extension |
| CDH Investments | Series C |
| CNCB Investment | Series C |
| Hillhouse Investment | Series B |
| Housen Care Brothers | Series C Extension |
| CCB International | Series C |
| GL Ventures | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
Partnered with Instituto Butantan to expand access in Brazil.
- Oct 29, 2025
Partnered with GC Cell to enter the Korean market.
IASO BIO Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IASO BIO's valuation, stock price, and market status.
